Published November 12, 2020 | Version Accepted Version + Supplemental Material
Journal Article Open

Synthesis and Biological Evaluation of Pyrroloindolines as Positive Allosteric Modulators of the α1β2γ2 GABA_A Receptor

Abstract

γ-Aminobutyric acid type A (GABA_A) receptors are key mediators of central inhibitory neurotransmission and have been implicated in several disorders of the central nervous system. Some positive allosteric modulators (PAMs) of this receptor provide great therapeutic benefits to patients. However, adverse effects remain a challenge. Selective targeting of GABA_A receptors could mitigate this problem. Here, we describe the synthesis and functional evaluation of a novel series of pyrroloin-dolines that display significant modulation of the GABA_A receptor, acting as PAMs. We found that halogen incorporation at the C5 position greatly increased the PAM potency relative to the parent ligand, while substitutions at other positions generally decreased potency. Mutagenesis studies suggest that the binding site lies at the top of the transmembrane domain.

Additional Information

© 2020 American Chemical Society. Received 18 June 2020. Accepted 15 September 2020. Published online 21 September 2020. We thank Alex Maolanon and Katie Chan for early synthesis efforts, as well as Chris B. Marotta and Kristina Daeffler for performing the preliminary Cys-loop screen. We are grateful to Scott Virgil and the Caltech Center for Catalysis and Chemical Synthesis for access to analytical equipment and assistance with performing preparative chiral HPLC and SFC resolutions. S.E.R. is a Heritage Medical Research Institute Investigator. Financial support from the NIH (S.E.R. R35GM118191-01) is gratefully acknowledged. Author Contributions. All authors have given approval to the final version of the manuscript. The authors declare no competing financial interest.

Attached Files

Accepted Version - ml0c00340.pdf

Supplemental Material - ml0c00340_si_001.pdf

Files

ml0c00340.pdf

Files (14.3 MB)

Name Size
md5:640837c4a07388be5009364155c0a1b9
2.7 MB Preview Download
md5:b04b2c658ed4846369bd64f83496fec5
11.5 MB Preview Download

Additional details

Identifiers

PMCID
PMC7667864
Eprint ID
105531
Resolver ID
CaltechAUTHORS:20200924-152452617

Funding

NIH
R35GM118191-01

Dates

Created
2020-09-24
Created from EPrint's datestamp field
Updated
2023-07-17
Created from EPrint's last_modified field

Caltech Custom Metadata